| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1997;29:514.)
© 1997 American Heart Association, Inc.
State-of-the-Art-Lecture |
From the Second Department of Medicine and Department of Radiology (S.N., T.M.), Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto City, Japan.
Reprint requests to Dr Satoshi Morimoto, Second Department of Medicine, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto city 602, Japan
| Abstract |
|---|
|
|
|---|
Key Words: rostral ventrolateral medulla neurovascular compression magnetic resonance imaging pulsatile compression neurogenic hypertension essential hypertension sympathetic nerve activity
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
MRI studies were performed on these subjects with an SMT-150x (1.5 T, Shimadzu). Proton density-weighted fast SE images (repetition time/effective echo time, 5000/23 ms) were obtained in axial and coronal views. To obtain high-quality images, a high-resolution (0.4x0.4 mm/pixel) 512x512 matrix with 3-mm slice thickness was used. Two neuroradiologists, unaware of each subjects medical history, assessed all the MRI scans to determine whether there was neurovascular compression of the retro-olivary sulcus of the medulla oblongata at the level of the root-entry zone of the glossopharyngeal and the vagus nerves, assumed to be the surface of RVLM.14 Compression was recognized when contact and depression of the RVLM was observed in the axial or coronal view.
Experimental Studies
All experiments were carried out acutely in male Wistar rats weighing between 300 and 400 g purchased from Charles River Breeding Laboratories (Kanagawa, Japan). Animal care and procedures conformed to the position of the American Heart Association on research animal use. After anesthetized with urethane (100 mg/100 g IP), each rat was mounted on a stereotaxic apparatus (David Kopf Instruments) in the supine position. The lower trachea was cannulated, and the rats were artificially ventilated at a rate of 60 breaths/min with a respirator (Ealing Co, Ltd) and were paralyzed with decamethonium bromide (0.2 mg/100 g IV).
Catheters were inserted separately in the right femoral artery for recording arterial pressure and heart rate and in the right femoral vein for drug injections. The splanchnic nerve was placed over a bipolar stainless steel electrode, and spike potentials were amplified and counted as described in detail elsewhere.19 The ventral surface of the medulla oblongata was then exposed by occipital craniotomy. The RVLM was identified by the pressor response of more than 25 mm Hg of mean arterial pressure by microinjection of L-glutamate monosodium (300 ng, 100 nL saline).20,21
A polyurethane cannula (outer diameter: 1.5 mm) was connected to a computer-controlled pneumatic pump,22 and a rubber membrane was stuck to the opposite end. By pumping air triggered with or without electrocardiogram (ECG), the membrane pulsated and the pressure wave inside the cannula became like that of an arterial pressure wave. The duration of air compression was set to be 50 ms. The rubber membrane of the cannula was lowered to the ventral surface of the medulla oblongata 1 mm dorsally from the line of the dura mater. Changes of arterial pressure, heart rate, and sympathetic nerve activity by pulsatile compression of the RVLM were monitored under several conditions: (1) ECG-triggered pulsatile compression of the RVLM (peak value of the pressure inside the cannula: 300 mm Hg); (2) ECG-triggered pulsatile compression of regions around the RVLM (peak value of the pressure inside the cannula: 300 mm Hg); (3) ECG-triggered pulsatile compression of the RVLM at various strengths (ie, peak value of the pressure inside the cannula: 0, 100, 200, and 300 mm Hg); (4) pulsatile compression of the RVLM at various rates (ie, 0, 100, 200, 300, and 400 cycles/min; peak value of the pressure inside the cannula: 300 mm Hg); and (5) ECG-triggered pulsatile compression of the RVLM after intravenous injection with hexamethonium (2.5 mg/100 g) or RVLM injection of kainic acid (8 nmol, 100 nL saline).23,24 Furthermore, plasma levels of epinephrine and norepinephrine were measured by high-performance liquid chromatography with electrochemical detection or by radioimmunoassay, respectively, after ECG-triggered pulsatile compression of the RVLM for 5 minutes.
Statistical Analysis
A
2 test was applied to determine if there were significant differences between groups in neurovascular compression. Pulsatile compression-response curve data were analyzed by ANOVA followed by Fishers multiple-range test. Pressor responses of pulsatile compression of the RVLM after pretreatment with hexamethonium or kainic acid were compared with sham rats by nonpaired t test. Plasma levels of catecholamines were also compared with sham rats by nonpaired t test.
| Results |
|---|
|
|
|---|
|
Neurovascular compression of the RVLM was observed in 14 (74%) of 19 patients with essential hypertension. In contrast, neurovascular compression was observed in only 1 (11%) of 9 patients with secondary hypertension and in only 2 (13%) of 16 normotensive subjects. The incidence of observed neurovascular compression in the essential hypertension group was significantly higher than that in the secondary hypertension group or the normotensive group (P<.01 for both groups, Fig 2).
|
Experimental Studies
Sympathetic nerve activity (rising ratio: 8.0±1.2%, P<.01), mean arterial pressure (from 88±22 to 105±22 mm Hg, P<.01), and heart rate (from 325±37 to 335±39 bpm, P<.01) were increased by ECG-triggered pulsatile compression of the RVLM (peak value of the pressure inside the cannula: 300 mm Hg), and these changes were normalized after cessation of the compression (Fig 3). On the other hand, these changes were not induced by pulsatile compression of regions around the RVLM (1 mm lateral, 1 mm medial, and 1 mm rostral). When the frequency of the compression or the pressure inside the cannula was changed, sympathetic nerve activity, mean arterial pressure, and heart rate were increased in a frequency-related or pressure-related manner, respectively. When the peak value of the pressure inside the cannula was 0 mm Hg or the rate of the pulsatile compression was 0/min, changes in sympathetic and cardiovascular activities were insignificant. The pressor response was abolished by ganglion blockade with hexamethonium or destruction of RVLM neurons with kainic acid (Fig 4). Plasma levels of epinephrine and norepinephrine were significantly increased by pulsatile compression of the RVLM (Fig 5).
|
|
|
At the end of the experiments, 100 nL of methylene blue dye was injected into the RVLM and 150 mL of 10% phosphate-buffered formaldehyde solution was transcardially infused. Serial sections (50 µm) were stained with Cresyl violet and examined by light microscopy for the location of injection sites with reference to a standard rat brain atlas.25 The methylene blue injection sites were located ventral to the nucleus ambiguus, caudal to the facial nucleus, and rostral to the lateral reticular nucleus, which was comparable to the RVLM.
| Discussions |
|---|
|
|
|---|
Jannetta et al9 reported that neurovascular compression of the RVLM was found in 51 of 53 hypertensive patients and in none of the 50 normotensive patients who underwent microvascular decompression for unrelated cranial nerve dysfunction such as hemifacial spasm or trigeminal neuralgia. Since then, several observations have indicated an association between essential hypertension and neurovascular compression of the RVLM.1116 In the present clinical studies as well, the incidence of observed neurovascular compression in the essential hypertension group was significantly higher than that in the secondary hypertension group or the normotensive group. In general, prolonged blood pressure elevation makes arteries elongated and tortuous. Therefore, it should be discussed whether neurovascular compression of the RVLM is a result or a cause of essential hypertension. In the present studies, however, the duration of hypertension and the degree of organ damage by hypertension were not significantly different between the two hypertension groups. Thus, it is not likely that neurovascular compression of the RVLM is the natural outcome of a chronic blood pressure elevation. Accordingly, we assume that neurovascular compression of the RVLM is a cause rather than a result of high blood pressure, at least in some patients with essential hypertension from the clinical studies.
It has been reported that chemical or electrical stimulation of the RVLM increases sympathetic nerve activity to elevate blood pressure.35 In the present experimental studies, we found that pulsatile compression of the RVLM increases sympathetic and cardiovascular activities. This finding is considered to be important because it implies that physical stimulation of the RVLM also increases sympathetic nerve activity and arterial pressure. Furthermore, although we cannot assume the long-term effects of pulsatile compression of the RVLM by the present acute experimental studies, these results support our presumption from the clinical studies described above.
Whether the pressor response in the present experimental studies is due to Cushings response need to be discussed. Cushings response is now considered to be from stretching of the receptive elements under the floor of the fourth ventricle by tissue distortion, either by direct pressure or by axial displacement of the brain stem.26 In the present studies, however, the pressor response was not induced by pulsatile compression of regions around the RVLM, and it was abolished after RVLM injection of kainic acid. Accordingly, it seems to be due to specific effects to the RVLM but not to Cushings response. On the other hand, when the peak value of the pressure inside the cannula was 0 mm Hg or the rate of the pulsatile compression was 0/min, sympathetic and cardiovascular activities were not significantly increased. Thus, it is likely that pulsatile compression but not nonpulsatile compression of the RVLM is important in the pressor response.
What is the mechanism of the pressor response by pulsatile compression of the RVLM? The following evidences indicate that it is via increased sympathetic nerve activity: (1) RVLM neurons are reported to project to the spinal preganglionic sympathetic neurons27,28; (2) pressor response by pulsatile compression of the RVLM was accompanied by an increase of sympathetic nerve activity in the present study; (3) plasma levels of epinephrine and norepinephrine were significantly increased by pulsatile compression of the RVLM; and (4) the pressor response was abolished after ganglion blockade with intravenously injected hexamethonium.
Microvascular decompression of the RVLM has been reported to improve hypertension.911 Jannetta et al9 reported that high blood pressure returned to normal in 32 and improved in 4 of 42 patients who were treated with left microvascular decompression of the RVLM. They reported development of hypertension by pulsatile compression of the RVLM and normalization of blood pressure by cessation of the pulsatile compression in a chronic experimental baboon model as well.10 We also observed normalization of increased sympathetic and cardiovascular activities by cessation of pulsatile compression of the RVLM in the present studies, although they were carried out acutely. Collectively, it is suggested that high blood pressure by pulsatile compression of the RVLM is reversible. Therefore, it might be possible that neurovascular decompression of the RVLM is selected as a therapy in the future for those who have neurovascular compression of the RVLM and antihypertensive medicine-resistant hypertension complicated with progressive target organ diseases.
In summary, the results from the MRI studies suggest that neurovascular compression of the RVLM is, at least in part, causally related to essential hypertension. This was supported by the results from the experimental studies indicating that pulsatile compression of the RVLM increases arterial pressure by enhancing sympathetic outflow.
| References |
|---|
|
|
|---|
2. Ciriello J, Caverson MM, Polosa C. Function of the ventrolateral medulla in the control of the circulation. Brain Res Rev. 1986; 11 : 359 391.
3. Ross CA, Ruggiero DA, Park DH, Joh TH, Sved AF, Fernandez-Pardal J, Saavedra JM, Reis DJ. Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J Neurosci. 1984; 4 : 474 494.[Abstract]
4. Kiely JM, Gordon FJ. Role of rostral ventrolateral medulla in centrally mediated pressor responses. Am J Physiol. 1994; 267 : 1549 1556.
5. Willette RN, Krieger AJ, Barcas PP, Sapru HN. Medullary gammaaminobutyric acid (GABA) receptors and the regulation of blood pressure in the rat.
J Pharmacol Exp Ther. 1983;
226
: 893
899.
6. Vasquez EC, Lewis SJ, Varner KJ, Brody MJ. Chronic lesion of rostral ventrolateral medulla in spontaneously hypertensive rats. Hypertension. 1992; 19 (suppl II): 154 158.
7. Jannetta PJ, Gendell HM. Neurovascular compression associated with essential hypertension. Neurosurgery. 1978; 2 : 165 . Abstract.[Medline] [Order article via Infotrieve]
8. Fein FM, Frishman W. Neurogenic hypertension related to vascular compression of the lateral medulla. Neurosurgery. 1980; 6 : 615 622.[Medline] [Order article via Infotrieve]
9. Jannetta PJ, Segal R, Wolfson SK. Neurogenic hypertension: etiology and surgical treatment, I: observations in 53 patients. Ann Surg. 1985; 201 : 391 398.[Medline] [Order article via Infotrieve]
10. Jannetta PJ, Segal R, Wolfson SK, Dujovny M, Semba A, Cook EE. Neurogenic hypertension: etiology and surgical treatment, IIobservations in an experimental nonhuman primate model. Ann Surg. 1985; 202 : 253 261.[Medline] [Order article via Infotrieve]
11. Yamamoto I, Yamada S, Sato O. Microvascular decompression for hypertension: clinical and experimental study. Neurol Med Chir (Tokyo). 1991; 31 : 1 6.
12. Kleineberg B, Becker H, Gaab MR. Neurovascular compression and essential hypertension: an angiographic study. Neuroradiology. 1991; 33 : 2 8.[Medline] [Order article via Infotrieve]
13. Kleinberg B, Becker H, Gaab MR, Naraghi R. Essential hypertension associated with neurovascular compression: angiographic findings. Neurosurgery. 1992; 30 : 834 841.[Medline] [Order article via Infotrieve]
14. Naraghi R, Gaab MR, Walter GF, Kleinberg B. Arterial hypertension and neurovascular compression at the ventrolateral medulla. J Neurosurg. 1992; 77 : 103 112.[Medline] [Order article via Infotrieve]
15. Naraghi R, Geiger H, Crnac J, Huk W, Fahlbusch R, Engels G, Luft FC. Posterior fossa neurovascular anomalies in essential hypertension. Lancet. 1994; 344 : 1466 1470.[Medline] [Order article via Infotrieve]
16. Akimura T, Furutani Y, Jimi Y, Saito K, Kashiwagi S, Kato S, Ito H. Essential hypertension and neurovascular compression at the ventrolateral medulla oblongata: MR evaluation. Am J Neuroradiol. 1995; 16 : 401 405.[Abstract]
17. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method.
Circulation. 1977;
55
: 613
618.
18. World Health Organization. 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Bull World Health Organ. 1993; 71 : 392 403.
19. Sasaki S, Nakata T, Kawasaki S, Hayashi J, Oguro M, Takeda K, Nakagawa M. Chronic central GABAergic stimulation attenuates hypothalamic hyperactivity and development of spontaneous hypertension in rats. J Cardiovasc Pharmacol. 1990; 15 : 706 713.[Medline] [Order article via Infotrieve]
20. Willette RN, Barcas PP, Krieger AJ, Sapru HN. Vasopressor and depressor areas in the rat medulla. Neuropharmacology. 1983; 22 : 1071 1079.[Medline] [Order article via Infotrieve]
21. Willette RN, Punnen S, Krieger AJ, Sapru HN. Cardiovascular control by cholinergic mechanisms in the rostral ventrolateral medulla.
J Pharmacol Exp Ther. 1984;
231
: 457
463.
22. Rogers RC. An inexpensive picoliter-volume pressure ejection system. Brain Res Bull. 1985; 15 : 669 671.[Medline] [Order article via Infotrieve]
23. Granata AR, Ruggiero DA, Park DH, Joh TH, Reis DJ. Brain stem area with C1 epinephrine neurons mediates baroreflex vasodepressor responses. Am J Physiol. 1985; 248 : 547 567.
24. Verberne AJM, Boudier HAJS. Midbrain central grey: regional haemodynamic control and excitatory amino acidergic mechanisms. Brain Res. 1991; 550 : 86 94.[Medline] [Order article via Infotrieve]
25. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. London, UK: Academic Press; 1986 .
26. Bell GM. Intracranial disorders and hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990: 703 709.
27. Strack AM, Sawyer WB, Platt KB, Loewy AD. CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res. 1989; 491 : 274 296.[Medline] [Order article via Infotrieve]
28. Brown DL, Guyenet PG. Cardiovascular neurons of brain stem with projections to spinal cord. Am J Physiol. 1984; 247 : 1009 1016.
This article has been cited by other articles:
![]() |
M. M. Sendeski, F. M. Consolim-Colombo, C. C. Leite, M. C. Rubira, P. Lessa, and E. M. Krieger Increased Sympathetic Nerve Activity Correlates With Neurovascular Compression at the Rostral Ventrolateral Medulla Hypertension, May 1, 2006; 47(5): 988 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Nicholas, S. J. D'Agostino, and S. J. Patel Arterial Compression of the Retro-Olivary Sulcus of the Ventrolateral Medulla in Essential Hypertension and Diabetes Hypertension, October 1, 2005; 46(4): 982 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ozer, O. Uzma, S. Albayram, H. Selcuk, C. Isilak, and N. Kocer Possible Electrical Stimulation on Rostral Ventrolateral Medulla That Causes Significant Hypertensive and Tachycardic Changes during Endovascular Treatment of a PICA Aneurysm Abutting the Left Medullary Sulcus AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 522 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zizka, J. Ceral, P. Elias, J. Tintera, L. Klzo, M. Solar, and L. Straka Vascular Compression of Rostral Medulla Oblongata: Prospective MR Imaging Study in Hypertensive and Normotensive Subjects Radiology, January 1, 2004; 230(1): 65 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Schobel, H. Frank, R. Naraghi, H. Geiger, E. Titz, and K. Heusser Hypertension in Patients with Neurovascular Compression Is Associated with Increased Central Sympathetic Outflow J. Am. Soc. Nephrol., January 1, 2002; 13(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Love and H. B. Coakham Trigeminal neuralgia: Pathology and pathogenesis Brain, December 1, 2001; 124(12): 2347 - 2360. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Gizewski, R. M. Spitthover, H. Wiedemayer, I. Wanke, T. Philipp, and M. Forsting Recurrent Neurovascular Hypertension: MR Findings Before and After Surgical Treatments AJNR Am. J. Neuroradiol., June 1, 2001; 22(6): 1168 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Menzel, H. Geiger, A. M. Sharma, and H. Hohenbleicher Neurovascular Contact of Cranial Nerve IX and X Root-Entry Zone in Hypertensive Patients Response Hypertension, June 1, 2001; 37 (6): e25 - e25. [Full Text] [PDF] |
||||
![]() |
H. Hohenbleicher, S. A. Schmitz, H.-C. Koennecke, R. Offermann, J. Offermann, H. Zeytountchian, K.-J. Wolf, A. Distler, and A. M. Sharma Neurovascular Contact of Cranial Nerve IX and X Root-Entry Zone in Hypertensive Patients Hypertension, January 1, 2001; 37(1): 176 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jordan, H. R. Toka, K. Heusser, O. Toka, J. R. Shannon, J. Tank, A. Diedrich, C. Stabroth, M. Stoffels, R. Naraghi, et al. Severely Impaired Baroreflex-Buffering in Patients With Monogenic Hypertension and Neurovascular Contact Circulation, November 21, 2000; 102(21): 2611 - 2618. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |